Aaron Dillow

400 total citations
12 papers, 330 citations indexed

About

Aaron Dillow is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Aaron Dillow has authored 12 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 8 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in Aaron Dillow's work include Virus-based gene therapy research (6 papers), Platelet Disorders and Treatments (5 papers) and Hemophilia Treatment and Research (5 papers). Aaron Dillow is often cited by papers focused on Virus-based gene therapy research (6 papers), Platelet Disorders and Treatments (5 papers) and Hemophilia Treatment and Research (5 papers). Aaron Dillow collaborates with scholars based in United States and Denmark. Aaron Dillow's co-authors include Timothy C. Nichols, Dwight A. Bellinger, Lili Wang, Roberto Calcedo, Inder M. Verma, James M. Wilson, Anja Ehrhardt, Hui Xu, Mark A. Kay and Elizabeth P. Merricks and has published in prestigious journals such as Blood, Journal of Thrombosis and Haemostasis and Thrombosis Research.

In The Last Decade

Aaron Dillow

12 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron Dillow United States 5 236 189 98 85 47 12 330
J Callegari Germany 5 429 1.8× 474 2.5× 76 0.8× 89 1.0× 80 1.7× 5 635
Erica Giuliani Italy 12 47 0.2× 125 0.7× 31 0.3× 50 0.6× 46 1.0× 26 339
Michael Lanuti United States 8 249 1.1× 161 0.9× 9 0.1× 115 1.4× 45 1.0× 8 371
Omar Abuzaitoun Israel 8 124 0.5× 48 0.3× 37 0.4× 42 0.5× 36 0.8× 10 277
Danielle E. Arnold United States 7 62 0.3× 66 0.3× 35 0.4× 56 0.7× 33 0.7× 18 255
Maria Carmen Martín Spain 9 35 0.1× 159 0.8× 20 0.2× 28 0.3× 96 2.0× 15 287
J P Okunewick United States 12 96 0.4× 62 0.3× 184 1.9× 63 0.7× 21 0.4× 60 396
Bradley C. Pietz United States 9 54 0.2× 64 0.3× 177 1.8× 13 0.2× 22 0.5× 13 316
Çiğdem Aydoğmuş Türkiye 9 39 0.2× 40 0.2× 17 0.2× 35 0.4× 43 0.9× 33 209
Maira da Costa Cacemiro Brazil 11 33 0.1× 115 0.6× 73 0.7× 13 0.2× 31 0.7× 21 279

Countries citing papers authored by Aaron Dillow

Since Specialization
Citations

This map shows the geographic impact of Aaron Dillow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Dillow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Dillow more than expected).

Fields of papers citing papers by Aaron Dillow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Dillow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Dillow. The network helps show where Aaron Dillow may publish in the future.

Co-authorship network of co-authors of Aaron Dillow

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron Dillow. A scholar is included among the top collaborators of Aaron Dillow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron Dillow. Aaron Dillow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Ragni, Margaret V., Rachel C. Jankowitz, Elizabeth P. Merricks, et al.. (2008). A phase II prospective open‐label escalating dose trial of recombinant interleukin‐11 in mild von Willebrand disease. Haemophilia. 14(5). 968–977. 25 indexed citations
2.
Margaritis, Paris, Élise Roy, Urs Giger, et al.. (2008). Successful treatment of canine hemophilia by continuous expression of canine FVIIa. Blood. 113(16). 3682–3689. 57 indexed citations
3.
Jankowitz, Rachel C., Margaret V. Ragni, Elizabeth P. Merricks, et al.. (2008). Recombinant Interleukin-11 (rhIL-11) in Women with Refractory Menorrhagia and Von Willebrand Disease.. Blood. 112(11). 1210–1210. 2 indexed citations
4.
Margaritis, Paris, Élise Roy, Shangzhen Zhou, et al.. (2008). Successful and Safe Treatment of Canine Hemophilia by Continuous Expression of Canine FVIIa: a Model for FVIII/FIX Gene-Based Bypassing Agents. Blood. 112(11). lba–4. 1 indexed citations
5.
Margaritis, Paris, Élise Roy, Elizabeth P. Merricks, et al.. (2007). Gene Transfer of Canine FVIIa Results in Partial Correction of Canine Hemophilia: A Model for FVIII/FIX Gene-Based Bypassing Agents.. Blood. 110(11). 195–195. 1 indexed citations
6.
Jankowitz, Rachel C., Elizabeth P. Merricks, Mark Kloos, et al.. (2007). RECOMBINANT IL-11 INCREASES VWF AND VWFMRNA IN TYPE 1 VWD. Journal of Thrombosis and Haemostasis. 5. O–T. 1 indexed citations
7.
Ezban, Mirella, Dorthe Viuff, Judi Møss, et al.. (2007). Single Dose Administration of rFVIIa and NN1731 in Two Hemophilia A Dogs.. Blood. 110(11). 3144–3144. 1 indexed citations
8.
Xu, Lingfei, Mark E. Haskins, Timothy C. Nichols, et al.. (2006). Immune response after neonatal transfer of a human factor IX-expressing retroviral vector in dogs, cats, and mice. Thrombosis Research. 120(2). 269–280. 32 indexed citations
9.
Merricks, Elizabeth P., et al.. (2006). Recombinant Human IL-11 (rhIL-11, Neumega®) Increases VWF Activity in Type 1 Von Willebrand Disease.. Blood. 108(11). 1003–1003. 1 indexed citations
10.
Wang, Lili, Roberto Calcedo, Timothy C. Nichols, et al.. (2005). Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy. Blood. 105(8). 3079–3086. 145 indexed citations
11.
12.
Ehrhardt, Anja, Hui Xu, Aaron Dillow, et al.. (2003). A gene-deleted adenoviral vector results in phenotypic correction of canine hemophilia B without liver toxicity or thrombocytopenia. Blood. 102(7). 2403–2411. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Callegari Breakdown of academic impact, for papers by Erica Giuliani Breakdown of academic impact, for papers by Michael Lanuti Breakdown of academic impact, for papers by Omar Abuzaitoun Breakdown of academic impact, for papers by Danielle E. Arnold Breakdown of academic impact, for papers by Maria Carmen Martín Breakdown of academic impact, for papers by J P Okunewick Breakdown of academic impact, for papers by Bradley C. Pietz Breakdown of academic impact, for papers by Çiğdem Aydoğmuş Breakdown of academic impact, for papers by Maira da Costa Cacemiro
Rankless by CCL
2026